Cash Payment and Counseling During Pregnancy (MARS)

November 29, 2023 updated by: Sabina Ulbricht, University Medicine Greifswald

Cash Payment and Counseling for Quitting Smoking During Pregnancy

Smoking during pregnancy has harmful effects on both mother and unborn child. Studies have shown that small rewards can help smokers to quit. In our current study, we ask how such rewards are most effective in supporting smoking cessation in pregnancy.

Study Overview

Detailed Description

We would like to include up to 15 pregnant women. Inclusion criteria are: (i) current pregnancy, between pregnancy week 15 and 23 and, (ii) current smoking of at least one cigarette per day. After an initial survey, the participating women are scheduled twice a week for counseling and evaluation of their smoking status.They will receive cash payment of 25 Euro if her carbon monoxide reading does not exceed the value "3", on two consecutive dates per week. A second survey will be conduced in pregnancy week 36 and a third survey, eight weeks postpartum.

Study Type

Interventional

Enrollment (Estimated)

15

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Greifswald, Germany, 17475
        • Recruiting
        • Institute for Comunity Medicine, Department Prevention Research and Social Medicine
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Current smoking, at least one cigarette per day
  • Pregnancy, between pregnancy week 15 and 23

Exclusion Criteria:

  • Inadequate language skills
  • Cognitive impairment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Cash payment and brief behavioral counseling
The intervention consists of in person counseling and cash payment. The participants receive 25 Euro per week if they have succeeded in quitting smoking. Quitting smoking is evaluated by carbon monoxide measurements twice a week.
The intervention consists of: (i) in person brief behavioral counseling, (ii) the evaluation of the smoking status using breath carbon monoxide, and (iii) cash payment of 25 Euro if the reading does not exceed a carbon monoxide value "3 ppm" ( ppm = parts per million) on two consecutive measurements per week. The intervention starts at the earliest in pregnancy week 15 and lasts until the delivery. If they relapse, the reward is not paid. However, in the following week they have the opportunity to quit smoking and being rewarded again.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Drop-out rate
Time Frame: Baseline up to pregnancy week 36
Measure: Analyses of drop-out rate (%)
Baseline up to pregnancy week 36

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Differences in number of cigarettes per day by self report
Time Frame: Baseline up to pregnancy week 36
Measure: (n), paper pencil assessment (self-report)
Baseline up to pregnancy week 36
Attempts to stop smoking by self report
Time Frame: Baseline up to pregnancy week 36
Measure: (n), paper pencil assessment (self-report)
Baseline up to pregnancy week 36
Attempts to stop smoking by carbon monoxide measurement
Time Frame: Baseline up to pregnancy week 36
Measure: Carbon monoxide level <4 ppm (ppm= parts per million, device: piCObaby smokerlyzer)
Baseline up to pregnancy week 36

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sabina Ulbricht, Prof. Dr., University Medicine Greifswald, Dep. Prevention Research and Social Medicine

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 15, 2020

Primary Completion (Estimated)

November 30, 2024

Study Completion (Estimated)

November 30, 2024

Study Registration Dates

First Submitted

September 25, 2020

First Submitted That Met QC Criteria

September 25, 2020

First Posted (Actual)

October 1, 2020

Study Record Updates

Last Update Posted (Actual)

November 30, 2023

Last Update Submitted That Met QC Criteria

November 29, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • Unimed

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Smoking Cessation

Clinical Trials on Cash payment and brief behavioral counseling

Subscribe